Smoking Gun: The Death Jab Failed – and the Evidence Was There Before FDA Approval
“If you take that vaccine, you’re [400%] more likely to die from a fatal cardiac arrest over the next six months than if you don’t.”
There’s a smoking gun against the vaccine agenda, and the evidence lies within Pfizer’s own clinical trials. Because when Pfizer went to the FDA to get their license, they failed one critical data point, all-cause mortality.
Let’s break it all down with the assistance of Robert F. Kennedy, Jr.
In the Pfizer clinical trials, they gave 22,000 people two COVID injections and 22,000 people fake vaccines.
• Of the 44,000 in total, one person died of COVID in the vaccine group, and two people died of COVID in the placebo group. So Pfizer, with the misleading measure of relative risk reduction, called their vaccine “100% effective” because two is 100% greater than one. But from the angle of absolute risk, it took 22,000 vaccines to save just one life from COVID.
• And over a 6-month period, 21 of the vaccinated people died of all causes, whereas only 17 people died in the placebo group, a 24% difference.
So what was killing those people in the vaccine group?
“It was cardiac arrest,” says RFK Jr.
There were five cardiac arrest deaths in the vaccine group and only one in the placebo group. What that means is that if you take that vaccine, you're [400%] more likely to die from a fatal cardiac arrest over the next six months than if you don't. What it also means is that for every life they save by preventing a death from COVID, they are killing four people from cardiac arrest.
So when Pfizer presented this data to the FDA, the FDA was supposed to assess all-cause mortality, give Pfizer’s vaccine a failing grade, tell them to make a better product and not come back until they could show it saves more lives than it kills. But instead, they rubberstamped them through, gave them the green light, and fast-tracked a vaccination campaign potentially responsible for up to 20 million deaths worldwide.
Thanks for making it to the end.
If you like my work and want to help keep it going, consider becoming a free or paid subscriber.